| Net income (loss) | |
| Depreciation and amortization | |
| Amortization of stock-based compensation costs | |
| Payment of lender fees related to debt issuance | |
| Provision for doubtful accounts | |
| Deferred income taxes | |
| (Gain) loss on divestiture of discontinued operations | |
| Other | |
| Accounts receivable | |
| Inventories and other assets | |
| Accounts payable | |
| Income taxes | |
| Due to third party payors | |
| Other accrued liabilities | |
| Net cash provided by operating activities | 36.08M |
| Routine capital expenditures | -21.87M |
| Development capital expenditures | -8.39M |
| Acquisitions, net of cash acquired | -49.33M |
| Sale of assets | 3.74M |
| Purchase of insurance subsidiary investments | -22.43M |
| Sale of insurance subsidiary investments | 31.88M |
| Net change in insurance subsidiary cash and cash equivalents | -14.68M |
| Change in other investments | |
| Other | -150K |
| Net cash used in investing activities | -81.18M |
| Proceeds from borrowings under revolving credit | 489.2M |
| Repayment of borrowings under revolving credit | -388.1M |
| Proceeds from issuance of senior unsecured notes | 0 |
| Proceeds from issuance of term loan, net of discount | 0 |
| Repayment of other long-term debt | |
| Payment of deferred financing costs | -50K |
| Issuance of common stock | 0 |
| Other | 35K |
| Net cash provided by (used in) financing activities | 84.47M |
| Change in cash and cash equivalents | 39.37M |
| Cash and cash equivalents at beginning of period | 100.06M |
| Cash and cash equivalents at end of period | 139.43M |
| Supplemental information: | |
| Issuance of common stock in RehabCare acquisition | |
| Financing costs/Interest payments | |
| Income tax payments (refunds) | |
| Supplemental information: | |
| Financing costs/Interest payments | |